Literature DB >> 26485683

TLR2-MyD88-NF-κB pathway is involved in tubulointerstitial inflammation caused by proteinuria.

Li-Hong Ding1, Dan Liu1, Min Xu1, Min Wu1, Hong Liu1, Ri-Ning Tang1, Kun-Ling Ma1, Ping-Sheng Chen1, Bi-Cheng Liu2.   

Abstract

Proteinuria is an important risk factor for chronic kidney diseases (CKD). Several studies have suggested that proteinuria initiates tubulointerstitial inflammation, while the mechanisms have not been fully understood. In this study, we hypothesized whether the activation of the TLR2-MyD88-NF-κB pathway is involved in tubulointerstitial inflammation induced by proteinuria. We observed expression of TLR2, MyD88, NF-κB, as well as TNF-α and IL-6 detected by immunohistostaining, Western blotting and real-time PCR in albumin-overloaded (AO) nephropathy rats. In vitro, we observed these markers in HK-2 cells stimulated by albumin. We used TLR2 siRNA or the NF-κB inhibitor BAY 11-7082 to observe the influence of TNF-α and IL-6 expression caused by albumin overload. Finally, we studied these markers in non-IgA mesangioproliferative glomerulonephritis (MsPGN) patients with different levels of proteinuria. It was demonstrated that expression of TLR2, MyD88 and NF-κB were significantly increased in AO rats and in non-IgA MsPGN patients with high levels of proteinuria, and TNF-α and IL-6 expressions were increased after NF-κB activation. Furthermore, TNF-α and IL-6 expression was positively correlated with the level of proteinuria. Albumin-overload induced TNF-α and IL-6 secretions by the TLR2-MyD88-NF-κB pathway activation, which could be attenuated by the TLR2 siRNA or BAY 11-7082 in HK-2 cells. In summary, we demonstrated that proteinuria may exhibit an endogenous danger-associated molecular pattern (DAMP) that induces tubulointerstitial inflammation via the TLR2-MyD88-NF-κB pathway activation.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IL-6; Proteinuria; TLR2–MyD88–NF-κB pathway; TNF-α; Tubulointerstitial inflammation

Mesh:

Substances:

Year:  2015        PMID: 26485683     DOI: 10.1016/j.biocel.2015.10.014

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  10 in total

1.  [Mechanism of Shenbing decoction Ⅲ in the treatment of proteinuria in chronic kidney disease: a network pharmacology-based study].

Authors:  Huaxi Liu; Zhihao Lü; Chunyang Tian; Wenkun Ouyang; Yifan Xiong; Yanting You; Liqian Chen; Yijian Deng; Xiaoshan Zhao; Xiaomin Sun
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-02-28

2.  Epidemiological characteristics of and risk factors for patients with postoperative acute kidney injury: a multicenter prospective study in 30 Chinese intensive care units.

Authors:  Yu Zhang; Li Jiang; Baomin Wang; Xiuming Xi
Journal:  Int Urol Nephrol       Date:  2018-02-26       Impact factor: 2.370

3.  IFN-τ Displays Anti-Inflammatory Effects on Staphylococcus aureus Endometritis via Inhibiting the Activation of the NF-κB and MAPK Pathways in Mice.

Authors:  Zhenbiao Zhang; Yingfang Guo; Yuzhu Liu; Chengye Li; Mengyao Guo; Ganzhen Deng
Journal:  Biomed Res Int       Date:  2017-02-26       Impact factor: 3.411

4.  Endothelial cells secreted endothelin-1 augments diabetic nephropathy via inducing extracellular matrix accumulation of mesangial cells in ETBR-/- mice.

Authors:  Hong-Hong Zou; Li Wang; Xiao-Xu Zheng; Gao-Si Xu; Yunfeng Shen
Journal:  Aging (Albany NY)       Date:  2019-03-29       Impact factor: 5.682

Review 5.  Crosstalk between tubular epithelial cells and glomerular endothelial cells in diabetic kidney disease.

Authors:  Si-Jie Chen; Lin-Li Lv; Bi-Cheng Liu; Ri-Ning Tang
Journal:  Cell Prolif       Date:  2020-01-11       Impact factor: 6.831

6.  International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people.

Authors:  Charlotte Gimpel; Carsten Bergmann; Detlef Bockenhauer; Luc Breysem; Melissa A Cadnapaphornchai; Metin Cetiner; Jan Dudley; Francesco Emma; Martin Konrad; Tess Harris; Peter C Harris; Jens König; Max C Liebau; Matko Marlais; Djalila Mekahli; Alison M Metcalfe; Jun Oh; Ronald D Perrone; Manish D Sinha; Andrea Titieni; Roser Torra; Stefanie Weber; Paul J D Winyard; Franz Schaefer
Journal:  Nat Rev Nephrol       Date:  2019-11       Impact factor: 28.314

Review 7.  Current understanding of the administration of mesenchymal stem cells in acute kidney injury to chronic kidney disease transition: a review with a focus on preclinical models.

Authors:  Lingfei Zhao; Fei Han; Junni Wang; Jianghua Chen
Journal:  Stem Cell Res Ther       Date:  2019-12-16       Impact factor: 6.832

8.  Integrative Informatics Analysis of Transcriptome and Identification of Interacted Genes in the Glomeruli and Tubules in CKD.

Authors:  Lingyun Liu; Fuzhe Ma; Yuanyuan Hao; Zhengzi Yi; Xiaoxia Yu; Bo Xu; Chengguo Wei; Jinghai Hu
Journal:  Front Med (Lausanne)       Date:  2021-02-12

9.  Association Between a TLR2 Gene Polymorphism (rs3804099) and Proteinuria in Kidney Transplantation Recipients.

Authors:  Shuang Fei; Zeping Gui; Dengyuan Feng; Zijie Wang; Ming Zheng; Hao Chen; Li Sun; Jun Tao; Zhijian Han; Xiaobing Ju; Min Gu; Ruoyun Tan; Xinli Li
Journal:  Front Genet       Date:  2022-02-21       Impact factor: 4.599

10.  Over-expressed microRNA-181a reduces glomerular sclerosis and renal tubular epithelial injury in rats with chronic kidney disease via down-regulation of the TLR/NF-κB pathway by binding to CRY1.

Authors:  Lei Liu; Xin-Lu Pang; Wen-Jun Shang; Hong-Chang Xie; Jun-Xiang Wang; Gui-Wen Feng
Journal:  Mol Med       Date:  2018-09-18       Impact factor: 6.354

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.